Stay updated on VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded site revision label Revision: v3.4.2. Removed older notices including the government funding disruption message and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a global notice about government funding lapse and NIH Clinical Center status. Updated site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and new metadata entries (Last Update Submitted that Met QC Criteria, Last Update Posted) plus a new revision identifier (v3.4.0). Removed or renamed older metadata items (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the previous revision (v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section showing the Illinois site for the study; removed the HHS Vulnerability Disclosure and Illinois Locations label, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check85 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; this is a minor metadata change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.